Skip to main content
Article thumbnail
Location of Repository

Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study

By Roger Bate, Philip Coticelli, Richard Tren and Amir Attaran


A range of antimalarial drugs were procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries, situated in the part of that continent and the world that is most highly endemic for malaria. Semi-quantitative thin-layer chromatography (TLC) and dissolution testing were used to measure active pharmaceutical ingredient content against internationally acceptable standards. 35% of all samples tested failed either or both tests, and were substandard. Further, 33% of treatments collected were artemisinin monotherapies, most of which (78%) were manufactured in disobservance of an appeal by the World Health Organisation (WHO) to withdraw these clinically inappropriate medicines from the market. The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies in the private sector risks patient safety and, through drug resistance, places the future of malaria treatment at risk globally

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2006). Antimalarial drug resistance and the importance of drug quality monitoring.
  2. (2006). Characterization of counterfeit artesunate antimalarial tablets from southeast Asia.
  3. (2006). Counterfeit and substandard antimalarial drugs in Cambodia.
  4. (2003). Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania.
  5. (2004). Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
  6. (1998). Interventions to improve the use of antimalarials in south-east Asia: an overview.
  7. (2007). Medicine Sellers and Malaria Treatment in Sub-Saharan Africa: What Do They Do and How Can Their Practice Be Improved?
  8. (2004). Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication.
  9. (2006). Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand.
  10. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria.
  11. (2005). The quality of sulphadoxinepyrimethamine and amodiaquine products in the Kenyan retail sector.
  12. (1992). The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya. Trans R Soc Trop Med Hyg
  13. (2004). WHO, the Global Fund and medical malpractice in malaria treatment.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.